Good ACE, bad ACE do battle in lung injury, SARS
- 1 August 2005
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 11 (8), 821-822
- https://doi.org/10.1038/nm0805-821
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Angiotensin-converting enzyme 2 protects from severe acute lung failureNature, 2005
- Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entryProceedings of the National Academy of Sciences of the United States of America, 2005
- Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly HumansJournal of Virology, 2005
- ACE2: from vasopeptidase to SARS virus receptorTrends in Pharmacological Sciences, 2004
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Lung pathology of fatal severe acute respiratory syndromeThe Lancet, 2003
- Nonpeptide Antagonists of AT1 Receptor for Angiotensin II Delay the Onset of Acute Respiratory Distress SyndromeThe Journal of pharmacology and experimental therapeutics, 2002
- A further Investigation INTO INFLUENZO-PNEUMOCOCCAL AND INFLUENZO-STREPTOCOCCAL SEPTICÆMIA: EPIDEMIC INFLUENZAL "PNEUMONIA" OF HIGHLY FATAL TYPE AND ITS RELATION TO "PURULENT BRONCHITIS."The Lancet, 1919